Drug intelligence / Profile preview

SII Yellow Fever Vaccine

Development stage
Unknown
Lead developer
Serum Institute of India
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

The SII Yellow Fever Vaccine is a live attenuated viral vaccine developed by the Serum Institute of India for the prevention of yellow fever. It contains the 17D-213 strain of the yellow fever virus, which is a derivative of the 17D-204 strain used in many currently licensed yellow fever vaccines. The vaccine is propagated in specific pathogen-free chick embryos and is designed to induce protective immunity against the yellow fever virus through a single dose. It is currently being evaluated in Phase III clinical trials, specifically targeting healthy infants aged 9 to 12 months in sub-Saharan Africa, to compare its safety and immunogenicity against the reference vaccine, STAMARIL. The development of this vaccine aims to address the global supply shortage of yellow fever vaccines.

Other names
Yellow fever vaccine (Serum Institute of India)SIIPL Yellow Fever Vaccine17D-213 strain vaccine

Beyond the preview

Go deeper on SII Yellow Fever Vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SII Yellow Fever Vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call